Surgical therapy of early esophageal cancer

2015 ◽  
pp. 189-198
Author(s):  
Toshitaka Hoppo ◽  
Blair A. Jobe
Keyword(s):  
Esophageal Cancer ◽  
Surgical Therapy ◽  
Early Esophageal Cancer

Endoscopic Surgery of the Broncho-esophageal Diseases. Endoscopic Mucosal Resection in Early Esophageal Cancer.

1996 ◽  
Vol 47 (2) ◽  
pp. 150-154 ◽  
Author(s):  
Hiroyasu Makuuchi ◽  
Hideo Shimada ◽  
Kyoichi Mizutani ◽  
Osamu Chino ◽  
Takao Machimura ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Endoscopic Mucosal Resection ◽  
Endoscopic Surgery ◽  
Early Esophageal Cancer ◽  
Esophageal Diseases ◽  
Mucosal Resection

THE ROLE OF BRACHYTHERAPY IN TREATMENT FOR ESOPHAGEAL CANCER

2017 ◽  
Vol 63 (4) ◽  
pp. 660-665
Author(s):  
Yelena Tyuryaeva
Keyword(s):  
Esophageal Cancer ◽  
Critical Review ◽  
Palliative Treatment ◽  
Combined Treatment ◽  
Neoadjuvant Treatment ◽  
Early Esophageal Cancer ◽  
Separate Section ◽  
Treatment Regimens ◽  
Contradictory Data

The article is devoted to various aspects of the use of intraluminal brachytherapy (IB) in treatment for esophageal cancer (EC). A critical review of the use of IB as a component of combined radiotherapy/chemoradiotherapy in neoadjuvant treatment regimens, for definitive CRT, as well as in palliative treatment of non-operable tumors of this localization is given. The contradictory data on the effectiveness of brachytherapy with locally distributed, inoperable EC are summarized. A separate section relates to the prospects for incorporating brachytherapy into combined treatment of early esophageal cancer. Carried out analysis testifies to the necessity of standardization of summary and daily doses of irradiation depending on the indications to the IB.

scholarly journals Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence

Cancers ◽  
2021 ◽  
Vol 13 (13) ◽  
pp. 3162
Author(s):  
Pierfrancesco Visaggi ◽  
Brigida Barberio ◽  
Matteo Ghisa ◽  
Mentore Ribolsi ◽  
Vincenzo Savarino ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Esophageal Cancer ◽  
Clinical Symptoms ◽  
Survival Rates ◽  
Screening Strategy ◽  
Cancer Surveillance ◽  
Blood Biomarkers ◽  
Early Esophageal Cancer ◽  
Novel Technologies ◽  
Bolus Impaction

Esophageal cancer (EC) is the seventh most common cancer and the sixth cause of cancer death worldwide. Histologically, esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) account for up to 90% and 20% of all ECs, respectively. Clinical symptoms such as dysphagia, odynophagia, and bolus impaction occur late in the natural history of the disease, and the diagnosis is often delayed. The prognosis of ESCC and EAC is poor in advanced stages, being survival rates less than 20% at five years. However, when the diagnosis is achieved early, curative treatment is possible, and survival exceeds 80%. For these reasons, mass screening strategies for EC are highly desirable, and several options are currently under investigation. Blood biomarkers offer an inexpensive, non-invasive screening strategy for cancers, and novel technologies have allowed the identification of candidate markers for EC. The esophagus is easily accessible via endoscopy, and endoscopic imaging represents the gold standard for cancer surveillance. However, lesion recognition during endoscopic procedures is hampered by interobserver variability. To fill this gap, artificial intelligence (AI) has recently been explored and provided encouraging results. In this review, we provide a summary of currently available options to achieve early diagnosis of EC, focusing on blood biomarkers, advanced endoscopy, and AI.

Tu1259 ESD for Early Esophageal Cancer at a Western Center: Practice Makes Perfect

2017 ◽  
Vol 85 (5) ◽  
pp. AB605-AB606 ◽  
Author(s):  
Stavros N. Stavropoulos ◽  
Krishna C. Gurram ◽  
Sriya Bhumi ◽  
Erin K. Ly ◽  
Rani J. Modayil ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Early Esophageal Cancer
Sign in / Sign up

Export Citation Format

Share Document